A Phase I Study of the Anti-Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory Malignancies

Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense

(2014) Kayluz Frias Boligan et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Phase I Trial of a Bivalent Gangliosides Vaccine in Combination with β-Glucan for High-Risk Neuroblastoma in Second or Later Remission

(2014) Brian H. Kushner et al.   CLINICAL CANCER RESEARCH

A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients

(2014) S. Alfonso et al.   CLINICAL CANCER RESEARCH

Racotumomab–alum vaccine for the treatment of non-small-cell lung cancer

(2014) Ana María Hernández et al.   Expert Review of Vaccines

Trilateral retinoblastoma: a systematic review and meta-analysis

(2014) Marcus C de Jong et al.   LANCET ONCOLOGY

Neuroblastoma in Iran: An Experience of 32 Years at a Referral Childrens Hospital

(2013) Gholamreza Bahoush Mehdiabadi et al.   Asian Pacific Journal of Cancer Prevention

Vaccination with anti-idiotype antibody ganglidiomab mediates a GD2-specific anti-neuroblastoma immune response

(2013) Holger N. Lode et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission

(2012) Nai-Kong V. Cheung et al.   JOURNAL OF CLINICAL ONCOLOGY

Children's Oncology Group's 2013 blueprint for research: Neuroblastoma

(2012) Julie R. Park et al.   PEDIATRIC BLOOD & CANCER

Complete Remission Following Decitabine/Dendritic Cell Vaccine for Relapsed Neuroblastoma

(2012) D. K. Krishnadas et al.   PEDIATRICS

Immune response to racotumomab in a child with relapsed neuroblastoma

(2012) C. Sampor et al.   Frontiers in Oncology

Detection of N-Glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: An Attractive Vaccine Target for Aggressive Pediatric Cancer

(2011) Alejandra M. Scursoni et al.   Clinical & Developmental Immunology

NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines

(2010) Luis E. Fernandez et al.   Clinical & Developmental Immunology

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

(2010) Alice L. Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cellular Immunotherapy for Neuroblastoma: A Review of Current Vaccine and Adoptive T Cell Therapeutics

(2009) C. Louis et al.   CURRENT PHARMACEUTICAL DESIGN

Detection and Characterization of N-Glycolyated Gangliosides in Wilms Tumor by Immunohistochemistry

(2009) Alejandra M. Scursoni et al.   PEDIATRIC AND DEVELOPMENTAL PATHOLOGY